Saturday 17 October 2026
Export GDRX’s income statement to Excel — free account
GoodRx Holdings, Inc.
GDRX Healthcare Health Information Services
GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024. In the quarter to June 2026, revenue fell 1.31%, EPS fell 25.0%, free cash flow grew 112.5% and total debt was flat, each against the same quarter a year earlier.
3.36
0.15
−4.27%
Follow GDRX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 5 | 5 |
| 4.90% | 4.54% | 3.22% | 2.52% | ||
| 2.37% | 2.18% | 1.24% | 0.89% | ||
ROIC |
6.35% | 6.49% | 5.59% | 5.59% | |
Return on Tangible Assets |
8.04% | 7.44% | 4.91% | 3.59% | |
Average Days of Receivables |
92.88 | 107.98 | 107.81 | 84.66 | |
Free Cash Flow per Share |
0.30 | 0.26 | 0.28 | 0.39 | |
Free Cash Flow |
104.93 | 93.88 | 96.54 | 131.70 | |
Capital Expenditures |
(74.83) | (74.02) | (73.79) | (69.88) | |
| Other line items | |||||
Cash ROIC |
7.70% | 6.87% | 7.18% | 9.21% | |
Accounts Receivable Turnover |
4.79 | 4.18 | 4.01 | 4.23 | |
Accounts Payable Turnover |
2.55 | 3.43 | 4.32 | 4.20 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
200.37 | 122.97 | 82.34 | 45.12 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.41) | (0.46) | (0.55) | (0.61) | |
Research and Development Expense of Revenue |
15.47% | 15.19% | 15.24% | 14.88% | |
Selling, General and Administrative Expense of Revenue |
57.50% | 55.91% | 55.75% | 55.11% | |
Share Based Compensation of Revenue |
9.95% | 9.62% | 9.39% | 8.80% | |
Interest Coverage |
1.91 | 2.05 | 1.87 | 1.84 | |
Operating CF/Net income |
5.66 | 5.52 | 8.29 | 12.41 | |
Depreciation/Fixed assets |
7.35 | 7.09 | 7.49 | 7.86 | |
Capex/Depreciation |
(0.90) | (0.85) | (0.84) | (0.77) | |
Revenue per Share |
2.31 | 2.24 | 2.31 | 2.31 | |
Operating CF per Share |
0.52 | 0.47 | 0.50 | 0.59 | |
Capex per Share |
(0.22) | (0.21) | (0.22) | (0.21) | |
Capex to Sales |
0.09 | 0.09 | 0.09 | 0.09 |
Columns are period end dates